Sign In
Buy BFLBY
Bilfinger SE Earnings Calls
| Release date | Nov 13, 2025 |
| EPS estimate | $0.324 |
| EPS actual | $0.338 |
| EPS Surprise | 4.04% |
| Revenue estimate | 1.56B |
| Revenue actual | 1.611B |
| Revenue Surprise | 3.29% |
| Release date | Aug 14, 2025 |
| EPS estimate | $0.308 |
| EPS actual | $0.298 |
| EPS Surprise | -3.22% |
| Revenue estimate | 1.469B |
| Revenue actual | 1.593B |
| Revenue Surprise | 8.46% |
| Release date | May 14, 2025 |
| EPS estimate | $0.213 |
| EPS actual | $0.92 |
| EPS Surprise | 331.99% |
| Revenue estimate | 1.352B |
| Revenue actual | 1.389B |
| Revenue Surprise | 2.74% |
| Release date | Mar 04, 2025 |
| EPS estimate | $0.254 |
| EPS actual | $1.43 |
| EPS Surprise | 462.33% |
| Revenue estimate | 1.409B |
| Revenue actual | 1.41B |
| Revenue Surprise | 0.0748% |
Last 4 Quarters for Bilfinger SE
Below you can see how BFLBY performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Mar 04, 2025 |
| Price on release | $14.53 |
| EPS estimate | $0.254 |
| EPS actual | $1.43 |
| EPS surprise | 462.33% |
| Date | Price |
|---|---|
| Feb 26, 2025 | $11.35 |
| Feb 27, 2025 | $11.35 |
| Feb 28, 2025 | $11.35 |
| Mar 03, 2025 | $12.25 |
| Mar 04, 2025 | $14.53 |
| Mar 05, 2025 | $15.22 |
| Mar 06, 2025 | $15.50 |
| Mar 07, 2025 | $15.23 |
| Mar 10, 2025 | $13.75 |
| 4 days before | 28.02% |
| 4 days after | -5.37% |
| On release day | 4.75% |
| Change in period | 21.15% |
| Release date | May 14, 2025 |
| Price on release | $17.32 |
| EPS estimate | $0.213 |
| EPS actual | $0.92 |
| EPS surprise | 331.99% |
| Date | Price |
|---|---|
| May 08, 2025 | $16.14 |
| May 09, 2025 | $16.19 |
| May 12, 2025 | $16.19 |
| May 13, 2025 | $17.60 |
| May 14, 2025 | $17.32 |
| May 15, 2025 | $17.32 |
| May 16, 2025 | $16.77 |
| May 19, 2025 | $16.77 |
| May 20, 2025 | $16.77 |
| 4 days before | 7.31% |
| 4 days after | -3.18% |
| On release day | 0% |
| Change in period | 3.90% |
| Release date | Aug 14, 2025 |
| Price on release | $22.15 |
| EPS estimate | $0.308 |
| EPS actual | $0.298 |
| EPS surprise | -3.22% |
| Date | Price |
|---|---|
| Aug 08, 2025 | $21.11 |
| Aug 11, 2025 | $21.11 |
| Aug 12, 2025 | $22.70 |
| Aug 13, 2025 | $22.15 |
| Aug 14, 2025 | $22.15 |
| Aug 15, 2025 | $22.15 |
| Aug 18, 2025 | $22.15 |
| Aug 19, 2025 | $22.15 |
| Aug 20, 2025 | $22.15 |
| 4 days before | 4.92% |
| 4 days after | 0.0068% |
| On release day | 0.0068% |
| Change in period | 4.93% |
| Release date | Nov 13, 2025 |
| Price on release | $22.84 |
| EPS estimate | $0.324 |
| EPS actual | $0.338 |
| EPS surprise | 4.04% |
| Date | Price |
|---|---|
| Nov 07, 2025 | $19.88 |
| Nov 10, 2025 | $19.92 |
| Nov 11, 2025 | $19.92 |
| Nov 12, 2025 | $19.92 |
| Nov 13, 2025 | $22.84 |
| Nov 14, 2025 | $21.05 |
| Nov 17, 2025 | $23.08 |
| Nov 18, 2025 | $23.08 |
| Nov 19, 2025 | $23.08 |
| 4 days before | 14.88% |
| 4 days after | 1.06% |
| On release day | -7.83% |
| Change in period | 16.10% |
Bilfinger SE Earnings Call Transcript Summary of Q3 2025
Bilfinger delivered a solid Q3 2025: revenue +8% (7% organic) to ~EUR 1.4bn, EBITA margin 5.8%, EPS EUR 1.47 and free cash flow improved ~30% to EUR 71m in the quarter. Orders received were broadly flat (+1% reported) and the order backlog rose ~7% y/y; year-to-date book-to-bill ~1.1. Management narrowed full‑year guidance: revenue EUR 5.3–5.5bn, EBITA margin 5.4–5.6% (targeting midpoints), and materially raised free cash flow guidance to EUR 300–360m. Segment highlights: E&M Europe delivered modest growth with small margin fluctuation; E&M International showed strong organic growth (esp. Middle East and US maintenance) but remains subscale in some regions; Technologies grew strongly (revenue +24% y/y) with margin improvement driven by life sciences and nuclear work and ‘‘derisking’’ of contract mix. Safety metrics mixed (TRIF up slightly Q/Q; LTIF improved). Innovation example: DRIS 2.0 portable insulation inspection that can cut turnaround time >10% and reduce costs. Management reiterated M&A appetite to achieve scale in North America and Middle East (bolt-ons done; potential larger deals considered if valuation-appropriate) and invited investors to a Capital Markets Day on Dec 2 where updated midterm targets will be presented. Net leverage remains low (~0.4), tax rate effect from German law change caused a one-time impact, and performance continues to show improved and sustainable cash conversion (9 consecutive quarters of positive cash flow).
